Efficacy and longevity of immune response to 3rd COVID-19 vaccine and effectiveness of a 4th dose in severely immunocompromised patients with cancer
View ORCID ProfileAstha Thakkar, Kith Pradhan, Benjamin Duva, Juan Manuel Carreño, Srabani Sahu, Victor Thiruthuvanathan, Sean Campbell, Sonia Gallego, Tushar D Bhagat, Johanna Rivera, Gaurav Choudhary, Raul Olea, Maite Sabalza, Lauren C. Shapiro, Matthew Lee, Ryann Quinn, Ioannis Mantzaris, Edward Chu, Britta Will, Liise-anne Pirofski, Florian Krammer, Amit Verma, Balazs Halmos
doi: https://doi.org/10.1101/2022.07.05.22277281
Astha Thakkar
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Kith Pradhan
2Department of Epidemiology and Population Health, Albert Einstein College of Medicine
Benjamin Duva
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Juan Manuel Carreño
3Department of Microbiology, Icahn School of Medicine at Mount Sinai
5Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai
Srabani Sahu
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Victor Thiruthuvanathan
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Sean Campbell
6Department of Pathology, Montefiore Medical Center
Sonia Gallego
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Tushar D Bhagat
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Johanna Rivera
7Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center
Gaurav Choudhary
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Raul Olea
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Maite Sabalza
8EUROIMMUN, US
Lauren C. Shapiro
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Matthew Lee
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Ryann Quinn
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Ioannis Mantzaris
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Edward Chu
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Britta Will
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Liise-anne Pirofski
7Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center
Florian Krammer
3Department of Microbiology, Icahn School of Medicine at Mount Sinai
4Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai
5Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai
Amit Verma
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Balazs Halmos
1Department of Oncology, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine
Posted July 06, 2022.
Efficacy and longevity of immune response to 3rd COVID-19 vaccine and effectiveness of a 4th dose in severely immunocompromised patients with cancer
Astha Thakkar, Kith Pradhan, Benjamin Duva, Juan Manuel Carreño, Srabani Sahu, Victor Thiruthuvanathan, Sean Campbell, Sonia Gallego, Tushar D Bhagat, Johanna Rivera, Gaurav Choudhary, Raul Olea, Maite Sabalza, Lauren C. Shapiro, Matthew Lee, Ryann Quinn, Ioannis Mantzaris, Edward Chu, Britta Will, Liise-anne Pirofski, Florian Krammer, Amit Verma, Balazs Halmos
medRxiv 2022.07.05.22277281; doi: https://doi.org/10.1101/2022.07.05.22277281
Efficacy and longevity of immune response to 3rd COVID-19 vaccine and effectiveness of a 4th dose in severely immunocompromised patients with cancer
Astha Thakkar, Kith Pradhan, Benjamin Duva, Juan Manuel Carreño, Srabani Sahu, Victor Thiruthuvanathan, Sean Campbell, Sonia Gallego, Tushar D Bhagat, Johanna Rivera, Gaurav Choudhary, Raul Olea, Maite Sabalza, Lauren C. Shapiro, Matthew Lee, Ryann Quinn, Ioannis Mantzaris, Edward Chu, Britta Will, Liise-anne Pirofski, Florian Krammer, Amit Verma, Balazs Halmos
medRxiv 2022.07.05.22277281; doi: https://doi.org/10.1101/2022.07.05.22277281
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2804)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12483)
- Forensic Medicine (10)
- Gastroenterology (793)
- Genetic and Genomic Medicine (4355)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2802)
- Health Policy (1040)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (457)
- Neurology (4118)
- Nursing (218)
- Nutrition (611)
- Oncology (2175)
- Ophthalmology (614)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1165)
- Primary Care Research (478)
- Public and Global Health (6714)
- Radiology and Imaging (1472)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (358)
- Surgery (467)
- Toxicology (57)
- Transplantation (196)
- Urology (173)